The Elsevier Office of Continuing Medical Education and Excerpta Medica would appreciate your opinion, to assist us in the evaluation of the effectiveness of this activity and to identify your ongoing educational needs.

Please complete this evaluation form. You must complete this evaluation form to receive acknowledgement for completing this activity.

*
*
*
*
*
*
*
PoorFairGoodVery goodExcellent
Recommend SMA gene profiling before other testing as the most efficient means of diagnosing SMA
Classify SMA type when evaluating patients, based on neurological examination and gene profiling
Select and appropriately use the standardized assessment tools/tests to monitor for clinical changes in patients with SMA
List key unmet needs in the management of SMA and understand how these gaps are being addressed with novel treatments
Describe the benefits of the first treatment approved for the management of SMA
Identify possible roles of other treatments currently in development, and identify patients who would most probably benefit from these therapies
Develop a comprehensive care plan with parents and patients, in close cooperation with neurologists, physical therapists, respiratory therapists, and other members of the multidisciplinary team
*
NeverRarelySometimesMost of the timeAlwaysN/A
Use gene sequencing and deletion testing to confirm the diagnosis of SMA:
Utilize a multidisciplinary approach to maximize supportive care for patients with SMA
Consider nusinersen as a treatment option for patients with SMA
*
NeverRarelySometimesMost of the timeAlwaysN/A
Use gene sequencing and deletion testing to confirm the diagnosis of SMA
Utilize a multidisciplinary approach to maximize supportive care for patients with SMA
Consider nusinersen as a treatment option for patients with SMA
*
Strongly disagreeDisagreeNeutralAgreeStrongly agree
Overall, the activity met my learning needs
The information presented was without promotional or commercial bias
The content provided a fair and balanced coverage of the topic
The content was scientifically rigorous and evidence-based
The event provided appropriate and effective opportunities for active learning (e.g. discussion, Q&A)
The quality of the educational process was satisfactory and appropriate
The event promoted improvements or quality in health care
The information provided with regard to faculty financial relationships met my needs for disclosure
The speakers were knowledgeable and presented the information clearly
The format of the discussion was relevant and enhanced my knowledge of the subject
*
PoorFairGoodVery goodExcellent
John Day, MD, PhD
Thomas Crawford, MD
Russell Butterfield, MD, PhD
*
*

Attestation to time spent on activity:

The Elsevier Office of Continuing Medical Education designates this live activity for a maxiumum of 1.25 AMA PRA Category 1 CreditTM.

*